Table 3

Schedule of data collection

ItemsScreening period within 1 weekTreatment period
1–6 months
Follow-up period
7–12 months
Signed informed consent
Inclusion/exclusion criteria
Demographic data
Medical history, course of disease, treatment history
Combined diseases
Concomitant medications
Plaque characteristics
Blood lipid indicators
Efficacy of angina symptoms
SAQ
MACEs
hs-CRP
Vital signs
Blood, urine and stool routine
Liver and kidney function
Adverse events
eCRF examination
  • Vital signs: temperature, heart rates, breathing and blood pressure.

  • √represents the indicators tested in the specific time period.

  • CRP, C-reactive protein; eCRF, electronic case report form; MACE, major adverse cardiac event; SAQ, Seattle Angina Questionnaire.